Composition GHK-Cu: 50 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of three co-formulated peptides Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Analysis Report Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Botany 74 (11), 33133327
Recent Pat Inflammation Allergy Drug Discovery
doi: 10.3389/fphar.2026.1808167 Received 10 February 2026 Revised 09 March 2026 Accepted 09 March 2026 Published 07 April 2026 Volume 17 - 2026 Edited by Carmen De Miguel, University of Alabama at Birmingham, United States Reviewed by Alessio Mazzieri, USL Umbria 1, Italy Ubong Ekperikpe, Icahn School of Medicine at Mount Sinai, United States Updates Copyright 2026 He, Wu and Li
This oral formula offers a simple and efficient way to increase the bodys levels of glutathione without the inconvenience and cost of intravenous administration